Hospital Stay and Respiratory Infection

November 2, 2016 updated by: Marie Carmen Valenza, Universidad de Granada

Repercussion of Hospital Stay in Patients With Respiratory Infection

The acute respiratory infection is the fourth most common cause of hospital stay between elderly people. The purpose of this study is to evaluate the repercussion of hospital stay in hospitalized patients with a respiratory infection.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Acute respiratory infection is a serious infection that prevents normal breathing function. It refers to any of a number of infectious diseases involving the respiratory tract. Health conditions that increase the risk of a respiratory infection include: another lung condition, a heart condition, a kidney or liver condition and a lowered immune system. The hospital stay of this patients is approximately 7-10 days and it is important to study the effects of this stay in the physical and psycho-emotional characteristics of patients.

Study Type

Observational

Enrollment (Actual)

116

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Granada, Spain, 18071
        • Faculty of health Sciences. University of Granada

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Hospitalized patients with an acute respiratory infection

Description

Inclusion Criteria:

  • Diagnosis of respiratory infection
  • Age: more than 50 year.
  • Signed written consent.

Exclusion Criteria:

  • Heart disease and concomitant neurological condition.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
respiratory infection
Hospitalized patients with a respiratory infection
An assessment of the patients included in the study will be conducted
Other Names:
  • Descriptive

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Strength in upper and lower limbs
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 8 days
The quadriceps and the hand-grip strength is assessed using a dynamometer with a standard protocol allowing three attempts on each side. During each measurement, patients were sitting with their shoulder adducted and elbow flexed to 90°. The maximum value achieved was used in the analyses. This is important in order to quantify the increase of strength Kg/cm2 The test 2-minute step in place is also going to be used for this purpose, counting the times the patients go up the right knees in two minutes.
Participants will be followed for the duration of hospital stay, an expected average of 8 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of life
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 8 days
The quality of life associated with health is going to be measure with t the EuroQol-5 questionnaire.
Participants will be followed for the duration of hospital stay, an expected average of 8 days
Lung function
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 8 days
Lung function is going to be evaluated using a spirometer.
Participants will be followed for the duration of hospital stay, an expected average of 8 days
Activity monitoring
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 8 days
The accelerometer Armband is going to be used for activity monitoring. It measures the intensity of the activity during 12 hours.
Participants will be followed for the duration of hospital stay, an expected average of 8 days
Quality of sleep
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 8 days
Changes in quality of sleep. For this purpose, the participants are going to complete the Pittsburgh Quality of Sleep Index. This is a self-rating questionnaire with seven subscores that result in a global score between 0 and 21.
Participants will be followed for the duration of hospital stay, an expected average of 8 days
Mood
Time Frame: Participants will be followed for the duration of hospital stay, an expected average of 8 days
Mood in these patients will be measured by the Hospital Anxiety and Depression Scale.
Participants will be followed for the duration of hospital stay, an expected average of 8 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2014

Primary Completion (Actual)

May 1, 2014

Study Completion (Actual)

August 1, 2014

Study Registration Dates

First Submitted

January 22, 2014

First Submitted That Met QC Criteria

January 26, 2014

First Posted (Estimate)

January 28, 2014

Study Record Updates

Last Update Posted (Estimate)

November 3, 2016

Last Update Submitted That Met QC Criteria

November 2, 2016

Last Verified

November 1, 2016

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Respiratory Infection

Clinical Trials on Respiratory infection

Subscribe